Background-Extracellular signal-regulated kinases (ERKs) and calcineurin have been reported to play important roles in the development of cardiac hypertrophy. We examined here the relation between calcineurin and ERKs in cardiomyocytes. Methods and Results-Isoproterenol activated ERKs in cultured cardiomyocytes of neonatal rats, and the activation was abolished by chelation of extracellular Ca 2ϩ with EGTA, blockade of L-type Ca 2ϩ channels with nifedipine, or depletion of intracellular Ca 2ϩ stores with thapsigargin. Isoproterenol-induced activation of ERKs was also significantly suppressed by calcineurin inhibitors in cultured cardiomyocytes as well as in the hearts of mice. Isoproterenol failed to activate ERKs in either the cultured cardiomyocytes or the hearts of mice that overexpress the dominant negative mutant of calcineurin. Isoproterenol elevated intracellular Ca 2ϩ levels at both systolic and diastolic phases and dose-dependently activated calcineurin. Inhibition of calcineurin also attenuated isoproterenol-stimulated phosphorylation of Src, Shc, and Raf-1 kinase. The immunocytochemistry revealed that calcineurin was localized in the Z band, and isoproterenol induced translocation of calcineurin and ERKs into the nucleus. Conclusions-Calcineurin, which is activated by marked elevation of intracellular Ca 2ϩ levels by the Ca 2ϩ -induced Ca 2ϩ release mechanism, regulates isoproterenol-induced activation of ERKs in cardiomyocytes. (Circulation. 2001;104:102-108.)
C ardiac hypertrophy is observed in various cardiovascular diseases, including hypertension, valvular diseases, myocardial infarction, and cardiomyopathy. Clinical studies have demonstrated that cardiac hypertrophy is not only a cause of congestive heart failure but also an independent risk factor for myocardial infarction, arrhythmia, and sudden death. 1 Therefore, it is even more important to determine the molecular mechanism of the development of cardiac hypertrophy. A variety of stimuli, such as mechanical stress, ischemia, and neurohumoral factors, can induce cardiac hypertrophy. 2, 3 These growth stimuli activate multiple intracellular signal transduction pathways, which lead to the reprogramming of gene expressions and an increase in protein synthesis in cardiomyocytes. 2, 3 A number of intracellular signaling molecules, such as protein kinase C (PKC), tyrosine kinases, the mitogen-activated protein kinase (MAPK) family, and the Janus kinase/signal transducers and activators of transcription (JAK/STAT) family, have been reported to play important roles in the development of cardiac hypertrophy. 2, 3 In particular, extracellular signal-regulated kinases (ERKs) have been extensively investigated and found to play a pivotal role in hypertrophic responses of cardiomyocytes both in vitro 4, 5 and in vivo, 6, 7 although activation of ERKs does not always lead to cardiomyocyte hypertrophy. 8 Catecholamines not only modulate cardiac functions but also induce hypertrophic responses. 9, 10 Both in vivo and in vitro studies demonstrate that the ␤-adrenergic receptor agonist isoproterenol (ISO) induces expression of protooncogenes and cardiac hypertrophy. 9, [11] [12] [13] We have reported that ISO activates ERKs through both G s -and G i -dependent pathways and induces cardiomyocyte hypertrophy. 13 Bogoyevitch et al 12 indicated that ISO activates ERKs through Ca 2ϩ . We also observed that Ca 2ϩ is involved in norepinephrine-induced activation of ERKs. 10 Ca 2ϩ regulates a number of cellular events, such as contraction, fertilization, differentiation, growth, and survival. 14 In response to stimuli, many cells increase their cytosolic Ca 2ϩ levels. 14 Intracellular Ca 2ϩ usually mediates cellular events through Ca 2ϩ -binding proteins. Among them, calmodulin (CaM) is a major Ca 2ϩbinding protein present in all eukaryotic cells. 15 Overexpression of CaM has been reported to induce proliferative and hypertrophic growth of cardiomyocytes in transgenic mice. 16 Ca 2ϩ /CaM activates various functional molecules, including Ca 2ϩ /CaM-dependent protein kinases (CaMKs) and phosphatases. 17, 18 CaMKII is a ubiquitous serine/threonine protein kinase that is involved in diverse functions of cells ranging from contraction, secretion, and synaptic transmission to gene expression. 17 CaMKII regulates phenylephrine-induced gene expression of atrial natriuretic peptide in cardiomyocytes. 19 Calcineurin is a ubiquitously expressed protein phosphatase that plays a pivotal role in neuronal functions and immunoreactions. 18 Recently, calcineurin has attracted great attention as a critical molecule that induces cardiac hypertrophy. 20 Overexpression of calcineurin and of its downstream transcription factor nuclear factor of activated T cells (NFAT) 3 induced marked cardiac hypertrophy in transgenic mice, whereas calcineurin inhibitors suppressed phenylephrine-and angiotensin II (Ang II)-induced cardiomyocyte hypertrophy in vitro. 20 We examined here how Ca 2ϩ is involved in ISO-induced activation of ERKs in cardiomyocytes.
Methods

Cell Culture and Transfection
Cardiomyocytes from ventricles of 1-day-old Wistar rats were cultured as previously described. 10, 13 A cDNA encoding constitutively active mutants of the calcineurin A subunit (CACnA) was constructed by deleting the autoinhibitory (carboxy terminus) and the CaM-binding domains of CnA through introducing a stop codon after N407 amino acids. 21 The dominant negative mutants of CnA (DNCnA) were obtained from CACnA by mutating histidine at position 160, a calcineurin active site, to glutamine. 21 The DNCaMKII was constructed by substituting alanine for lysine at position 43 of CaMKII␦. 22 Amounts of 7.5 g of DNCnA and CACnA in pMep vector and DNCaMKII in pcDNA3 vector or other plasmids were transfected into cultured cardiomyocytes with 2.5 g of hemagglutinin-tagged ERK2 (HA-ERK2) DNA by the calcium phosphate method. 13
Transgenic Mice
HA-tagged DNCnA was subcloned into the ␣-myosin heavy chain promoter-containing expression vector. 20 The linearized DNA was injected into pronuclei of eggs from BDF1 mice, which were transferred into the oviducts of pseudopregnant ICR mice. The transgene was identified by polymerase chain reaction with transgene-specific primers. 23 Northern blot analysis using cDNA probe corresponding to N1 to 407 of DNCnA and Western blot analysis using an anti-HA antibody and an anti-CnA antibody raised against a carboxy terminus peptide of the CnA␤, respectively, revealed that the DNCnA gene and protein were specifically and abundantly expressed in the hearts of transgenic mice (manuscript in preparation). There was no significant difference in the expression levels of endogenous CnA between the transgenic and wild-type mice. In addition, we also observed that there are no significant differences in blood pressure, heart weight, endocardiography, cardiomyocyte size, and myocardial fibrosis at control state between the transgenic and wild-type mice (manuscript in preparation). Twelveweek-old DNCnA transgenic mice and wild-type littermate mice were used in the present study. All protocols were approved by the guidelines of the University of Tokyo.
ERK Activity
The activity of ERKs was measured by use of the myelin basic protein (MBP)-containing gel as previously described. 13 The activ-ity of transfected HA-ERK2 was assayed by use of MBP as a substrate after immunoprecipitation with an anti-HA antibody (Mitsubishi Biochemical Laboratories) as previously described. 13 
Intracellular Ca 2؉ Levels
Intracellular Ca 2ϩ levels were measured with the Ca 2ϩ fluorescent dye indo 1 (Dojin Kagaku) as described previously. 24 The ratio of 400-nm fluorescence to 500-nm fluorescence, which was collected from the myocytes illuminated by 360-nm light, was used as an indicator for intracellular Ca 2ϩ concentration. 24
Calcineurin Activity
The activity of calcineurin was determined with phosphorylated GST-RII peptide as a substrate as previously described, 25 with some modifications. We separated CaM-bound calcineurin (active calcineurin, Ͼ100 kDa) from free calcineurin (inactive calcineurin, Ͻ100 kDa) using Ultrafree-MC centrifugal filter units (Millipore).
Activation of Src, Shc, and Raf-1 Kinase
Src and Shc were immunoprecipitated with anti-Src and anti-Shc antibodies (Santa Cruz Biotechnology), respectively. The immune complexes were subjected to SDS-PAGE, and the blotted membranes (Millipore) were hybridized with an anti-phosphotyrosine antibody (4G10) (Santa Cruz Biotechnology). Immunoreactivity was detected with an enhanced chemiluminescence (ECL) reaction system (Amersham) according to the manufacturer's directions. Raf-1 kinase activity was determined by use of a specific substrate rMAPKK as described previously. 10
Immunocytochemistry
Cardiomyocytes cultured on glass cover slides in serum-free DMEM for 24 hours were incubated with phalloidin-TRITC, anti-␣-actinin, anti-CnA␤, or anti-phospho-ERK antibodies (Santa Cruz Biotechnology), and then with secondary antibodies according to the manufacturer's directions.
Statistical Analysis
Statistical comparison was carried out within 3 independent experiments by 1-way ANOVA and Dunnett's t test. Values of PϽ0.05 were considered statistically significant.
Results
Involvement of ERKs in ISO-Induced Cardiac Hypertrophy
We first determined in the present study whether activation of ERKs is involved in ISO-induced cardiac hypertrophy. Stimulation with ISO (1 mol/L for 48 hours) induced a significant increase in the cell size and improved the organization of myofibrils ( Figure 1B ) in cultured cardiomyocytes compared with saline incubation ( Figure 1A ), whereas addition of ISO together with PD98059 (50 mol/L), a specific inhibitor of MEK1, to the culture medium did not induce hypertrophy ( Figure 1C ). Injection of ISO (1 mg · kg body wt Ϫ1 · d Ϫ1 IP) for 7 days increased left ventricular mass ( Figure 1E ) and transverse diameter of cardiac myocytes ( Figure 1H ) compared with saline injection in mice ( Figure 1D and 1G ). Injection of PD98059 (100 mg · kg body wt Ϫ1 · d Ϫ1 IP) significantly suppressed the ISO-induced morphological changes in the heart ( Figure 1F and 1I) . These results suggest that ERKs play an important role in ISO-induced cardiac hypertrophy.
Involvement of Ca 2؉ in Activation of ERKs in Cardiomyocytes
We next examined whether Ca 2ϩ is involved in the activation of ERKs by ISO in cultured cardiomyocytes. ISO (10 mol/L for 8 minutes) strongly activated ERKs, as reported before. 13 The activation of ERKs was completely suppressed by pretreatment with EGTA (5 mmol/L for 10 minutes), an extracellular Ca 2ϩ chelator, or nifedipine (1 mol/L for 30 minutes), an L-type Ca 2ϩ channel antagonist (Figure 2A ), suggesting that the Ca 2ϩ influx from extracellular space through L-type Ca 2ϩ channels is required for ISO-induced activation of ERKs. To elucidate whether Ca 2ϩ -induced Ca 2ϩ release (CICR) is involved in the activation of ERKs, intracellular Ca 2ϩ stores were depleted by pretreatment with thapsigargin (2 mol/L for 24 hours), an inhibitor of sarcoplasmic reticulum Ca 2ϩ -ATPase. Thapsigargin significantly suppressed ISO-induced activation of ERKs (Figure 2A ). Pretreatment of cardiomyocytes with EGTA, nifedipine, or thapsigargin alone did not affect basal activity of ERKs ( Figure 2B ).
Roles of Ca 2؉ -Binding Proteins in Activation of ERKs
We further examined which Ca 2ϩ -binding proteins are involved in ISO-induced activation of ERKs in cardiomyocytes. The CaM inhibitor W7 strongly inhibited ISO-evoked ERK activation ( Figure 3A ). Cyclosporin A (CsA), a highly specific calcineurin inhibitor, also abolished the activation of ERKs, whereas the CaMKII inhibitor KN93 had no effect ( Figure 3A ). FK506, another calcineurin inhibitor, showed the same inhibitory effects on ISO-induced activation of ERKs (data not shown). We also examined the role of calcineurin in ERK activation induced by other ligands. CsA had marginal effects on phenylephrine-and Ang II-induced activation of ERKs in cardiomyocytes ( Figure 3B ), suggesting that the role of calcineurin in ERK activation is different among ligands.
To confirm the pharmacological results, we used the genetic strategy. We transfected the cDNA plasmids of DNCnA, CACnA, or DNCaMKII with HA-ERK2 into cardiomyocytes. There were no significant differences in expression levels of HA-ERK2 among samples ( Figure 4A ). Although overexpression of DNCnA had no effect on the basal ERK2 activity, it strongly suppressed ISO-induced activation of ERK2 ( Figure 4B ). To the contrary, overexpression of DNCaMKII did not affect ISO-induced activation of ERK2. Overexpression of CACnA significantly increased the activity of ERK2. These results collectively suggest that calcineurin, but not CaMKII, plays a pivotal role in ISO-induced ERK activation in cardiomyocytes.
We also addressed the role of calcineurin in vivo using wild-type mice treated with FK506 and DNCnA transgenic mice, which overexpress DNCnA specifically in the heart ( Figure 5A ). 23 Injection of ISO (0.5 g · kg body wt Ϫ1 · min Ϫ1 IV) into the left femoral vein for 10 minutes significantly activated 42-kDa ERK in the heart of wild-type mice ( Figure  5B ). When the mice were pretreated with injection of FK506 (1 mg · kg body wt Ϫ1 · d Ϫ1 IM), the ERK activation was significantly suppressed. Moreover, ISO did not increase the activity of ERKs in the heart of DNCnA transgenic mice ( Figure 5B ).
Elevation of Intracellular Ca 2؉ Levels and Activation of Calcineurin
We examined whether ISO increases intracellular Ca 2ϩ levels and activates calcineurin in cultured cardiomyocytes. We measured intracellular Ca 2ϩ levels using the Ca 2ϩ fluorescent dye indo 1. ISO (100 nmol/L) significantly increased the beating rate of cardiomyocytes and induced a rapid and significant increase in cytosolic Ca 2ϩ levels at both the systolic and diastolic phases ( Figure 6A ). ISO (10 mol/L) rapidly increased the activity of calcineurin ( Figure 6B ). The activity of calcineurin was significantly increased from 2 minutes, peaked at 5 minutes, and decreased thereafter. An increase in the activity of calcineurin was detected at 10 nmol/L of ISO, and the maximum activation was observed at 10 mol/L of ISO ( Figure 6C) . Similarly, intravenous injection of ISO (0.5 g · kg Ϫ1 · min Ϫ1 ) for 5 minutes activated calcineurin in the heart of wild-type but not of DNCnA transgenic mice ( Figure 6D ).
Involvement of Calcineurin in ISO-Induced Activation of Src, Shc, and Raf-1 Kinase
We have reported that ISO activates ERKs through both G s and G i proteins and that the G i pathway involves Src, Shc, Ras, and Raf-1 kinase in cardiomyocytes. 13 We examined whether calcineurin is involved in activation of these molecules. ISO rapidly induced tyrosine phosphorylation of Src and Shc and activation of Raf-1 kinase (Figure 7) . The phosphorylation and activation of these proteins were significantly attenuated by pretreatment with CsA. These results suggest that calcineurin regulates the ISO-induced activation of ERKs possibly through the Src/Shc/Raf-1 kinase pathway.
Localization of Calcineurin and Its Translocation
We finally examined the localization of calcineurin and its translocation by ISO in cultured cardiomyocytes by immunocytochemistry. Immunostaining with the anti-CnA antibody showed prominent signals on band-like structures (Figure 8Aa and 8Ac ), which were also stained with the anti-␣actinin antibody (Figure 8Ab and 8Ac) . These results suggest that calcineurin is localized in the Z band of cardiomyocytes. Representative tracing of intracellular Ca 2ϩ concentration transients before and after addition of ISO (100 nmol/L). B and C, Activation of calcineurin by ISO in cardiomyocytes. Cardiomyocytes were incubated with ISO 10 mol/L for indicated period of time (B) or at indicated concentration for 5 minutes (C). D, Activation of calcineurin by ISO in heart of mice. Saline or ISO (0.5 g · kg body wt Ϫ1 · min Ϫ1 IV) was injected for 5 minutes (nϭ3). Calcineurin activity was determined as described in Methods. Results are meanϮSEM from 3 independent experiments (controlϭ100%). *PϽ0.05 vs control or saline injection in WT mice. **PϽ0.05 vs ISO injection in TG mice.
There were no positive signals in unstimulated cells immunostained with the anti-phospho-ERK antibody (data not shown). When cardiomyocytes were incubated with ISO for 10 minutes, calcineurin was translocated into and around the nucleus (Figure 8Ba ), and activated ERKs were also observed around the nucleus (Figure 8Be ). Pretreatment with CsA significantly attenuated the ISO-induced translocation of calcineurin and ERKs (Figure 8Bb and 8Bf) . Conversely, 12-O-tetradecanoylphorbol-13-acetate (TPA), a PKC activator, induced activation and translocation of ERKs ( Figure  8Bg) ; however, it did not induce translocation of calcineurin (Figure 8Be ). Pretreatment with CsA did not affect TPAinduced ERK translocation (Figure 8Bh ).
Discussion
Although it has been reported that ISO activates ERKs and induces cardiac hypertrophy, 9, [11] [12] [13] the role of ERKs in the development of cardiac hypertrophy remains unclear. In the present study, ISO-induced cardiac hypertrophy was suppressed by inhibition of ERK activation, suggesting that ERKs play an important role in ISO-induced cardiac hypertrophy. We also observed that ISO-induced cardiac hypertrophy was also significantly suppressed by pretreatment with CsA both in cultured cardiomyocytes and in mice and that ISO induced less cardiac hypertrophy in the DNCnA transgenic mice than in wild-type mice (unpublished results), suggesting an involvement of the Ca 2ϩ -dependent phosphatase calcineurin in ISO-induced cardiac hypertrophy.
Ca 2ϩ influx from the extracellular space through L-type Ca 2ϩ channels and Ca 2ϩ release from intracellular Ca 2ϩ stores were critically involved in ISO-induced activation of ERKs in cardiomyocytes. Many studies have reported that ISO activates L-type Ca 2ϩ channels through G s /PKA in cardiomyocytes. 26, 27 We recently reported that ISO activates ERKs through both G s /PKA-and G i /Ras-dependent pathways. 13 Although some reports indicate that activation of G i increases Ca 2ϩ entry via T-type Ca 2ϩ channels in adrenal glomerulosa cells 28 and that G i protein directly regulates inositol 1,4,5triphosphate-dependent Ca 2ϩ release in smooth muscle, 29 it remains to be determined whether the G i pathway is involved in Ca 2ϩ influx in cardiomyocytes.
Ca 2ϩ usually regulates cellular events by binding to Ca 2ϩbinding proteins, such as CaM. 15 We observed here that inhibition of CaM by W7 attenuated ISO-induced ERK activation, indicating that Ca 2ϩ mediates ISO-induced activation of ERKs through binding to CaM in cardiomyocytes. The Ca 2ϩ /CaM complex exerts its functions through downstream effectors, such as CaMKII and calcineurin. 17, 18 Calcineurin has been reported to be involved in the activation of ERKs in cultured mouse M1 myeloid leukemic cells. 30 In the present study, pretreatment of cultured cardiomyocytes with calcineurin inhibitors and overexpression of DNCnA in cardiomyocytes inhibited ISO-induced activation of ERKs. Moreover, inhibition of calcineurin in vivo by the inhibitor or overexpression of the DNCnA also suppressed ISO-induced activation of ERKs in the heart. These results clearly indicate that calcineurin is required for ISO-induced ERK activation. The calcineurin inhibitor did not strongly suppress phenylephrine-and Ang II-induced ERK activation, suggesting that phenylephrine and Ang II activate ERKs through calcineurinindependent mechanisms. Overexpression of CACnA activated ERKs in cardiomyocytes, suggesting that activation of calcineurin is enough to activate ERKs. It was recently reported that ERKs are activated in the heart of hypertrophic calcineurin transgenic mice. 31 CaMKII has been reported to be involved in Ang II-induced ERK activation in smooth muscle cells. 22 In this study, however, CaMKII was not involved in ISO-induced ERK activation. Although we do not know at present why calcineurin but not CaMKII mediates ISO-induced ERK activation in cardiomyocytes, stimuli and cell types may determine which Ca 2ϩ -dependent molecules mediate the activation of ERKs.
The mechanism of how calcineurin activates ERKs is unknown at present; several lines of evidence, however, have suggested the existence of a cross-talk between the calcineurin and MAPK pathways. [31] [32] [33] Calcineurin has been Figure 7 . Activation of Src, Shc, and Raf-1 kinase. Cardiomyocytes pretreated with saline or CsA for 30 minutes were exposed to ISO for indicated period of time. Cell lysates were immunoprecipitated with antibodies to Src, Shc, or Raf-1 kinase, respectively. Tyrosine phosphorylation of Src and Shc and activation of Raf-1 kinase was detected as described in Methods. Representative autoradiograms. reported to regulate the activity of JNK, a member of MAPK family, in concert with PKC. 31 It has been reported that calcineurin potentiates the formation of cAMP in adrenal glomerulosa cells 32 and that calcineurin is required for cyclic stretch-induced Src activation in endothelial cells. 33 Because both cAMP and Src are upstream activators of ERKs in cardiomyocytes, 13 calcineurin may be involved in the activation of ERKs through cAMP and Src. Our present study showed that inhibition of calcineurin significantly suppressed tyrosine phosphorylation of Src and Shc and activation of Raf-1 kinase, suggesting that calcineurin is involved in ISO-induced activation of the Src/Shc/Raf-1 kinase pathway. It remains to be determined how calcineurin activates this pathway in cardiomyocytes.
ISO induced a rapid and significant increase in cytosolic Ca 2ϩ levels during both the systolic and diastolic phases and significantly increased the activity of calcineurin. It has been reported that ISO activates PKA, which phosphorylates L-type Ca 2ϩ channels, leading to an enhanced Ca 2ϩ influx. 26 Ca 2ϩ influx through L-type Ca 2ϩ channels induces a large amount of Ca 2ϩ release from intracellular Ca 2ϩ stores by the CICR mechanism. 34, 35 It has been unknown how calcineurin is activated in cardiomyocytes, in which intracellular Ca 2ϩ levels go up and down at every contraction-relaxation cycle. The release of Ca 2ϩ from intracellular Ca 2ϩ stores was necessary for ISO-induced activation of calcineurin (data not shown), suggesting that a large increase in intracellular Ca 2ϩ levels is required for activation of calcineurin in cardiomyocytes. Calcineurin was localized in the Z band of cardiomyocytes. In cardiomyocytes, the Z band is close to the T tubules. 36, 37 Because voltage-dependent Ca 2ϩ channels are abundant in the T tubules and Ca 2ϩ -releasing channels are also localized in the membrane of sarcoplasmic reticulum, which is close to the T tubules, 37,38 the local Ca 2ϩ concentration around the Z band might be quite high. Calcineurin has been reported to be activated by sustained increase in Ca 2ϩ . 18 Because ISO strongly elevated both systolic and diastolic Ca 2ϩ levels by a Ca 2ϩ influx from the extracellular space through L-type Ca 2ϩ channels and by CICR, free Ca 2ϩ levels around calcineurin in the Z band might be high enough to activate calcineurin. ISO induced rapid translocation of calcineurin as well as ERKs into the nucleus. Although activated calcineurin has been reported to form complexes with NFAT and to translocate into the nucleus, 21 the role of translocation of calcineurin in the activation of ERKs remains to be determined.
